Method of treatment of cancers
US-12036259-B2 · Jul 16, 2024 · US
Composition for promoting the activity of peroxisome proliferator-activated receptor-delta
US10183048B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10183048-B2 |
| Application number | US-201013511964-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 25, 2010 |
| Priority date | Nov 26, 2009 |
| Publication date | Jan 22, 2019 |
| Grant date | Jan 22, 2019 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed is a composition for promoting the activity of peroxisome proliferator-activated receptor-δ (PPAR-δ), which contains Artemisia vulgaris extracts or Artemisia capillaris extracts as active ingredients. The composition is effective in strengthening muscles, improving endurance and memory, and preventing and alleviating the symptoms of dementia or Parkinson's disease.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for promoting activity of peroxisome proliferator-activated receptor delta (PPAR-δ) in skeleton muscle cells of a subject in need, comprising: administering an effective amount of Artemisia iwayomogi ethanol extract as an active ingredient, wherein the subject is in need of strengthening muscles or improving endurance. 2. The method for promoting activity of peroxisome proliterator-activated receptor delta (PPAR-δ) in skeleton muscle cells according to claim 1 , wherein the Artemisia iwayomogi ethanol extract is administered in a form of a composition and the composition comprises the Artemisia iwayomogi ethanol extract in an amount of 1-80 wt % based on the total weight of the composition. 3. A method for promoting activity of peroxisome proliferator-activated receptor delta (PPAR-δ) in skeleton muscle cells of a subject in need, comprising: administering an effective amount of Artemisia iwayomogi ethanol extract as an active ingredient, wherein the subject is in need of strengthening muscles or improvinq endurance, wherein the active ingredient regulates expression of one or more genes that promote fat metabolism in at least skeletal muscle cells, thereby strengthening muscle cells or improving endurance in the subject.
Assignees
Inventors
Classifications
Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title
- A61K36/282Primary
Artemisia, e.g. wormwood or sagebrush · CPC title
for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia · CPC title
Anti-Parkinson drugs · CPC title
Plant extracts, their artificial duplicates or their derivatives · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10183048B2 cover?
- Disclosed is a composition for promoting the activity of peroxisome proliferator-activated receptor-δ (PPAR-δ), which contains Artemisia vulgaris extracts or Artemisia capillaris extracts as active ingredients. The composition is effective in strengthening muscles, improving endurance and memory, and preventing and alleviating the symptoms of dementia or Parkinson's disease.
- Who is the assignee on this patent?
- Cho Si Young, Park Pil Joon, Lee Ji Hae, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification A61K36/282. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).